Cantor Fitzgerald, L.P. ("Cantor"), a leading global financial services firm, and Silverstein Properties, Inc. ("Silverstein"), a leading global full-service real estate development, investment, and ...

Equities research analysts at Cantor Fitzgerald issued their FY2025 earnings per share (EPS) estimates for Impinj in a report issued on Thursday, February 27th. Cantor Fitzgerald analyst T. Jensen ...

Esperion Therapeutics (NASDAQ:ESPR – Get Free Report) is expected to issue its quarterly earnings data before the market opens on Tuesday, March 4th. Analysts expect the company to announce earnings ...

We recently compiled a list of the 10 Best Stocks Under $50 to Buy Right Now. In this article, we are going to take a look at ...

Blackwell is still in its early days, but at $11 billion, it made up nearly a third of Nvidia's data-center revenue, Cantor Fitzgerald analyst C.J. Muse noted. (Nvidia's data-center business ...

Fintel reports that on February 26, 2025, Cantor Fitzgerald downgraded their outlook for Jazz Pharmaceuticals (NasdaqGS:JAZZ) ...

Gil Luria, D.A. Davidson & Co managing director, and C.J. Muse, Cantor Fitzgerald senior managing director, join CNBC's ...

In a report released today, Andres Sheppard from Cantor Fitzgerald maintained a Buy rating on Joby Aviation (JOBY – Research Report), with a ...

In a report released yesterday, Kristen Kluska from Cantor Fitzgerald maintained a Buy rating on Sarepta Therapeutics (SRPT – Research Report), ...